doxepin has been researched along with Hearing Loss, Noise-Induced in 1 studies
Doxepin: A dibenzoxepin tricyclic compound. It displays a range of pharmacological actions including maintaining adrenergic innervation. Its mechanism of action is not fully understood, but it appears to block reuptake of monoaminergic neurotransmitters into presynaptic terminals. It also possesses anticholinergic activity and modulates antagonism of histamine H(1)- and H(2)-receptors.
doxepin : A dibenzooxepine that is 6,11-dihydrodibenzo[b,e]oxepine substituted by a 3-(dimethylamino)propylidene group at position 11. It is used as an antidepressant drug.
Hearing Loss, Noise-Induced: Hearing loss due to exposure to explosive loud noise or chronic exposure to sound level greater than 85 dB. The hearing loss is often in the frequency range 4000-6000 hertz.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Su, YT | 1 |
Meng, XX | 1 |
Zhang, X | 1 |
Guo, YB | 1 |
Zhang, HJ | 1 |
Cheng, YP | 1 |
Xie, XP | 1 |
Chang, YM | 1 |
Bao, JX | 1 |
1 other study available for doxepin and Hearing Loss, Noise-Induced
Article | Year |
---|---|
Doxepin Mitigates Noise-induced Neuronal Damage in Primary Auditory Cortex of Mice via Suppression of Acid Sphingomyelinase/Ceramide Pathway.
Topics: Acoustic Stimulation; Animals; Antidepressive Agents, Tricyclic; Auditory Cortex; Ceramides; Doxepin | 2017 |